Prematurity is the major risk factor for late-onset group B streptococcus disease

Journal of Infectious Diseases

Volumn 188, Issue 2, 2003, Pages 267-271

  Lin, Feng Ying C ^a   Weisman, Leonard E ^b   Troendle, James ^a   Adams, Karen ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM CULTURE; CHILD; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEWBORN SEPSIS; ONSET AGE; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; SCREENING; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

AFRICAN AMERICANS; AGE OF ONSET; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0041814648     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/376457     Document Type: Article

References (37)

1. Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987; 110:31-6.
2. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of cohort study in metropolitan Atlanta. J Infect Dis 1990; 162:672-7.
3. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342:15-20.
4. Aber RC, Akkeb B, Howell JT, Wilkenson HW, Facklam RR. Nosocomial transmission of group B streptococci. Pediatrics 1976; 58:346-53.
5. Steere AC, Aber RC, Warford LR, et al. Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr 1975; 87:784-7.
6. Boyer KM, Vogel LC, Gotoff SP, Gadzala CA, Stringer J, Maxted WR. Nosocomial transmission of bacteriophage type 7/11/12 group B streptococci in a special care nursery. Am J Dis Child 1980; 134:964-6.
7. Band JD, Clegg JW 2nd, Hayes PS, Facklam RR, Stringer J, Dixon RE. Transmission of group B streptococci. Am J Dis Child 1981; 135:355-8.
8. Noya FJD, Rench MA, Metzger TG, Colman G, Naidoo J, Baker CJ. Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 1987; 155:1135-44.
9. Takayanagi T, Tanaka H, Yoshinaga M. An outbreak of group B streptococcus infection in a neonatal nursery and subsequent trial for prophylaxis of nosocomial transmission. Acta Paediatrica Japonica 1994; 36:88-90.
10. Bingen E, Denamur E, Lambert-Zechovsky N, et al. Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection. J Infect Dis 1992; 165:569-73.
11. Schreiner RL, Coates T, Shackelford PG. Possible breast milk transmission of group B streptococcal infection. J Pediatr 1977; 91:159.
12. Kenny JF. Recurrent group B streptococcal disease in an infant associated with the ingestion of infected mother's milk. J Pediatr 1977; 91:158-9.
13. Olver W, Bond D, Boswell T, Watkin SL. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed 2000; 83:F48-9.
14. Rand TH. Group B streptococcal cellulitis in infants: a disease modified by prior antibiotic therapy or hospitalization? Pediatrics 1988; 81:63-5.
15. Di John D, Krasinski K, Lawrence R, et al. Very late onset of group B streptococcal disease in infants with the human immunodeficiency virus. Pediatr Infect Dis J 1990; 9:925-8.
16. Lin FY, Philips JB 3rd, Azimi PH, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by type la group B streptococcus: a multicenter, seroepidemiology study. J Infect Dis 2001; 184:1022-8.
17. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996; 45(RR-7):1-24.
18. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility, to neonatal group B streptococcal infection. N Engl J Med 1976; 294:753-6.
19. Hemming VG, Hall RT, Rhodes PG, Shigeoka AO, Hill HR. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest 1976; 58:1379-87.
20. Klegerman ME, Boyer KM, Papierniak E, Gotoff SP. Estimation of the protective level of IgG antibody to the type-specific polysaccharide of group B streptococcus type 1a. J Infect Dis 1983; 148:648-55.
21. Baker CJ, Edwards MS, Kasper DL. Immunogenicity of polysaccharides from type III group B streptococcus. J Clin Invest 1978; 61:1107-10.
22. Wald ER, Snyder MJ, Gutberlet RL. Group B beta-hemolytic streptococcal colonization: acquisition, persistence, and effect of umbilical cord treatment with triple dye. Am J Dis Child 1977; 131:178-80.
23. Regan J, O'Neil J, Sprunt C, James JS. Persistent carriage of group B streptococci during the first 15 months of life: a major reservoir. Pediatr Res 1980; 14:563.
24. Baker CJ. Group B streptococcal infections. Adv Int Med 1980; 25:475-501.
25. Anthony BF, Okada DM. The emergence of group B streptococci in infection of the newborn infant. Annu Rev Med 1997; 28:355-69.
26. Hammerschlag MR, Baker CJ, Alpert S, et al. Colonization with group B streptococci in girls under 16 years of age. Pediatrics 1977; 60:473-6.
27. Paredes A, Wong P, Mason EO Jr, Tabler LH, Barrett FF. Nosocomial transmission of group B streptococci in a newborn nursery. Pediatrics 1977; 59:679-82.
28. Anthony BF, Okada DM, Hobel LJ. Epidemiology of the group B streptococci: maternal and nosocomial sources for infant acquisition. J Pediatr 1979; 95:431-6.
29. Bonadio WA, Jeruc W, Anderson Y, Smith D. Systemic infection due to group B beta-hemolytic streptococcus in children: a review of 75 outpatient-evaluated cases during 13 years. Clin Pediatr (Phila) 1992; 31:230-3.
30. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 1991; 77:604-10.
31. Newton ER, Butler MC, Shain RN, Sexual behavior and vaginal colonization by group B streptococci among minority women. Obstet Gynecol 1996; 88:577-82.
32. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999; 104:203-9.
33. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznick DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 2000; 96:498-503.
34. Meyn LA, Moore DM, Hillier SL, Krohn MA. Association of sexual activity with colonization and vaginal acquisition of group B streptococci in non-pregnant women. Am J Epidemiol 2002; 155:949-57.
35. Robbins JB, Schneerson R, Vann WF, Bryla DA, Fattom A. Prevention of systemic infections caused by group B streptococcusand Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. Ann NY Acad Sci 1995; 754:68-82.
36. Hillier SL, Baker CJ, Ferrieri, Krohn MA. Could a vaccine against group B streptococcus protect against vaginal colonization? [abstract G-154]. In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002:239.
37. Weisman LE, Anthony BF, Hemming VG, Fisher GW. A group B streptococcal polyvalent hyperimmune intravenous IgG in neonates with suspected sepsis. J Pediatr 1993; 122:929-37.